Autres langues Bukwang Pharmaceutical Co., Ltd.

Actions

A003000

KR7003000007

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
6 550 ^KRW	-2,53%		-0,76%	+7,38%

01/04	H Delta Private Equity Partnership a conclu l'acquisition d'une participation de 24,4 % dans Contera Pharma ApS auprès de Bukwang Pharmaceutical Co., Ltd. pour un montant de 6,3 milliards de KRW.	CI
26/03	Les actions de Bukwang Pharmaceutical bondissent suite à l'annonce du programme de rachat	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.	01/04
Bukwang Pharmaceutical Shares Surge Following Buyback Program Announcement	26/03
H Delta Private Equity Partnership agreed to acquire 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.	22/03
Bukwang Pharmaceutical : IR Fact Book 4Q23 (Reviewed by External Auditor)	15/03
Bukwang Pharmaceutical : IR presentation 4Q23 (Reviewed by External Auditor)	15/03
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
Bukwang Pharmaceutical Co., Ltd.(KOSE:A003000) dropped from KOSPI 200 Index	09/06/22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17/03/22
OCI Company Ltd. completed the acquisition of additional 10.878134% stake in Bukwang Pharmaceutical Co., Ltd. (KOSE : A003000) from Kim Sanghun and 8 other shareholders for approximately KRW 150 billion.	03/03/22
OCI Company Ltd. agreed to acquire an additional 10.878134% stake in Bukwang Pharmaceutical Co., Ltd. (KOSE : A003000) from Kim Sanghun and 8 other shareholders for approximately KRW 150 billion.	22/02/22
ImmPACT Bio USA Inc. announced that it has received $110.855843 million in funding from a group of investors	20/01/22
ImmPACT Bio USA Inc. announced that it expects to receive $110.855843 million in funding	14/01/22
Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21
Bukwang Pharmaceutical : confirmed Levovir showed tendency of reducing virus from Phase 2 clinical trial topline data	13/05/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bukwang Pharmaceutical Co., Ltd.

Actions

A003000

KR7003000007

Autres langues

Filtres